India vs Iraq: Treatment success rate for patients treated for MDR-TB
India
77.0%
in 2022
Iraq
76.0%
in 2022
India rank
61st
Iraq rank
64th
Treatment success rate for patients treated for MDR-TB over time
- India
- Iraq
How they compare
India currently reports 77.0% against 76.0% in Iraq, a difference of 1.0%.
The two have swapped places 4 times across 16 shared years of data; in 2007 it was India ahead.
India ranks 61st and Iraq ranks 64th of 163 countries.
Across the 3 decades both report, India averaged higher in 1 and Iraq in 2.
Head to head by decade
| Decade | India | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.7% | 32.0% | 16.7% | India |
| 2010s | 49.2% | 62.4% | 13.2% | Iraq |
| 2020s | 73.0% | 75.0% | 2.0% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, India or Iraq?
- India, at 77.0% against 76.0% in Iraq as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between India and Iraq?
- 1.0%, with India ahead.
- How many years of comparable data are there for India and Iraq?
- 16 years are reported by both, from 2007 to 2022.
- How do India and Iraq rank globally for treatment success rate for patients treated for mdr-tb?
- India ranks 61st and Iraq ranks 64th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.